Active Stocks in Focus: Ocwen Financial Corp. (NYSE:OCN), EdR (NYSE:EDR), Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Ocwen Financial Corp. (NYSE:OCN) reported that its writes open letter to homeowners concerning letter dating issues. CEO Ron Faris released statement that in recent days you may have heard about an investigation by the New York Department of Financial Services' into letters Ocwen sent to borrowers which were inadvertently misdated. Ocwen Financial Corp. (NYSE:OCN) has the market capitalization of 2.470 Billion. Shares of firm plunged -2.02% to close at $18.88 with the total traded volume of 3.85 Million.EdR (NYSE:EDR) released that its third quarter Reports funds from operations of $0.11 per share, in-line with the Capital IQ Consensus of $0.11; revenues surged 25.7 percent year/year to $54.7M as compared to the $49.05M consensus. EdR (NYSE:EDR) begun last trade with a price of $11.11 and throughout the trading session climbed at a high of $11.13. The day-trade ended with 0.09% to $11.13. The stock is going forward to its 52 week low with 34.66% and lagging behind from its 52 week high price with -0.98%. EDR last month stock price volatility remained 1.94%.Akebia Therapeutics, Inc. (NASDAQ:AKBA) released that its optimistic top-line results from its Phase 2b placebo-controlled trial of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease. The study achieved its primary endpoint as well as AKB-6548 was generally well tolerated, confirming that the once-daily, oral therapy can successfully increase and maintain hemoglobin levels. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock price closed at $13.97 with the total traded volume of 2.24 Million shares. Its market capitalization is 255.7 Million. The stock owned by the Financial Institutions was 44.70% while by insiders was 33.00%.